Mackay Shields LLC Adverum Biotechnologies, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.36 - $10.56 $240,576 - $756,096	-71,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $265,762 - $412,132	-28,700 Reduced 28.61%	71,600 $706,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $200,736 - $290,904	20,400 Added 25.53%	100,300 $1.09 Million
Q3 2020 Nov 04, 2020	BUY	$10.3 - $21.64 $431,570 - $906,716	41,900 Added 110.26%	79,900 $823,000
Q2 2020 Jul 31, 2020	BUY	$8.53 - $25.64 $324,140 - $974,320	38,000 New	38,000 $794,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $478M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.